What is the initial test order for a patient with polycythemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Initial Testing for Polycythemia

For a patient with high hemoglobin/polycythemia, the initial diagnostic workup should include complete blood count with peripheral blood smear, JAK2 V617F mutation testing, and serum erythropoietin level. 1

Diagnostic Approach

First-Line Testing

  1. Complete Blood Count (CBC) with peripheral blood smear

    • Evaluates hemoglobin, hematocrit, red blood cell count, white blood cell count, and platelet count
    • Peripheral smear helps identify abnormal cell morphology
    • Look for elevated hemoglobin (>18.5 g/dL in men, >16.5 g/dL in women) or hematocrit (>49% in men, >48% in women) 1
  2. JAK2 V617F mutation testing

    • Present in >95% of polycythemia vera cases 2
    • Helps distinguish between primary polycythemia (myeloproliferative neoplasm) and secondary causes
    • Essential for diagnosing masked polycythemia vera 1
  3. Serum erythropoietin level

    • Low levels suggest primary polycythemia (PV)
    • Normal or elevated levels suggest secondary polycythemia 1

Second-Line Testing (if initial tests are inconclusive)

  • JAK2 exon 12 mutation testing (if JAK2 V617F is negative but PV still suspected)
  • Bone marrow biopsy and aspiration (to evaluate megakaryocyte morphology and clustering, assess for reticulin fibrosis) 1
  • Arterial blood gas analysis (to rule out hypoxic causes)
  • Abdominal ultrasound (to evaluate for splenomegaly)

Differential Diagnosis

Primary Polycythemia

  • Polycythemia vera (PV) - a myeloproliferative neoplasm characterized by increased red blood cell mass and JAK2 mutation 2

Secondary Polycythemia

  1. Hypoxia-driven causes:

    • Chronic pulmonary disease
    • Sleep apnea
    • High altitude
    • Smoking
    • Congenital heart disease
  2. Non-hypoxia-driven causes:

    • Renal cell carcinoma
    • Uterine leiomyoma
    • Pheochromocytoma
    • Meningioma 1
  3. Relative polycythemia:

    • Dehydration
    • Diuretic use
    • Stress polycythemia (Gaisböck syndrome) 1

Clinical Pearls and Pitfalls

Important Clinical Features to Note

  • Pruritus (especially after warm shower)
  • Erythromelalgia (burning pain in extremities)
  • Transient visual changes
  • Splenomegaly with abdominal discomfort
  • History of unusual thrombosis (especially splanchnic vein thrombosis) 2

Common Pitfalls

  • Overlooking masked PV: Iron deficiency can normalize hemoglobin in PV patients 1
  • Missing secondary causes: When JAK2 mutation is absent, secondary causes must be thoroughly investigated 1
  • Neglecting relative polycythemia: Dehydration, diuretics, or smoking can cause relative polycythemia 1
  • Failing to recognize early PV: Cases with borderline elevated counts but with PV-related features may be missed 1

Management Considerations

If polycythemia vera is diagnosed:

  • Therapeutic phlebotomy (goal hematocrit <45%)
  • Low-dose aspirin (if no contraindications)
  • Risk stratification for consideration of cytoreductive therapy 2, 3

Remember that untreated patients with PV may survive only 6-18 months, whereas adequate treatment can extend life expectancy to more than 10 years 4. Therefore, prompt and accurate diagnosis is essential for improving outcomes.

References

Guideline

Myeloproliferative Neoplasms Diagnosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Polycythemia vera.

American family physician, 2004

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.